Groupe la Francaise boosted its position in shares of IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 20.6% during the second quarter, according to its most recent Form 13F filing with the Securities and E
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
Capital Fund Management S.A. lowered its holdings in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 43.0% in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The
Capital Counsel LLC NY lowered its stake in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 1.3% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Comm
Advisors Asset Management Inc. lowered its position in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 24.5% in the second quarter, according to the company in its most recent Form 13F filing with the Secu
CardioGenics (OTCMKTS:CGNH - Get Free Report) and IDEXX Laboratories (NASDAQ: IDXX - Get Free Report) are both medical companies, but which is the better business? We will compare the two companies ba
Idexx (IDXX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Does Idexx Laboratories (IDXX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Bell Asset Management Ltd lowered its stake in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 49.0% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securitie
IDEXX Laboratories' (IDXX) recent jump has investors questioning whether it's still the best bet—or if a stronger opportunity exists elsewhere. A closer look at its key competitor suggests there may
Idexx (IDXX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
From a technical perspective, Idexx Laboratories (IDXX) is looking like an interesting pick, as it just reached a key level of support. IDXX recently overtook the 20-day moving average, and this sugge
ABN Amro Investment Solutions bought a new position in shares of IDEXX Laboratories, Inc. (NASDAQ: IDXX) in the second quarter, according to the company in its most recent 13F filing with the Securiti
The steep increase in pet healthcare costs have doubled over the past five years, according to NPR.

Baron Asset Fund Q3 2025 Performance Review

02:30am, Thursday, 13'th Nov 2025
Baron Asset Fund underperformed for a second consecutive quarter as U.S. equities continued their strong rally from the market lows reached on April 8. From a sector perspective, stock selection in IT
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE